Biblio Discovery — Demo Discovery Service

1 hasil untuk "Rumeli Roy"

Menampilkan 1–1 · 0,34 detik · RSS

  1. Artikel Jurnal

    Outcomes and toxicities of triple metronomic chemotherapy with low-dose nivolumab and axitinib in unresectable, recurrent, and metastatic head-and-neck squamous cell carcinomas: A real-world retrospective analysis from a resource-constrained setting

    Rumeli Roy; Vanita Noronha; Nandini Menon dkk.

    Cancer Research, Statistics, and Treatment, Vol. 9 No. 1 · 2026 · Inggris · DOAJ Dikeluarkan Scopus 2023

    Background: This study aimed to evaluate whether the addition of an anti-vascular endothelial growth factor (VEGF) agent, axitinib, to oral metronomic chemotherapy and low-dose nivolumab could improve survival outcomes without increasing toxicities in patients with advanced, unresectable, or…